Age-Dependent Sensitivity to Streptozotocin of Pancreatic Islets Isolated from Female NOD Mice

References

• Rossini A. A., Mordes J. P., Handler E. S. Speculations on etiology of diabetes mellitus. Tumbler hypothesis. Diabetes 1988; 37: 257–261
   PubMed Web of Science ®Google Scholar
• Maclaren N., Atkinson M. Is insulin-deepndent diabetes mellitus environmentally induced?. N Eng J Med 1992; 327: 348–349
   PubMed Web of Science ®Google Scholar
• Rossini A. A., Greiner D. L., Friedman H. P., Mordes J. P. Immunopathogenesis of diabetes mellitus. Diabetes Reviews 1993; 1: 43–75
   Google Scholar
• Leslie R. D.G., Elliott R. B. Early environmental events as a cause of IDDM—Evidence and implications. Diabetes 1994; 43: 843–850
   PubMed Web of Science ®Google Scholar
• Todd J. A. Genetic control of autoimmunity in type 1 diabetes. Immunology Today 1990; 11: 122–128
   PubMedGoogle Scholar
• Helgason T., Jonasson M. R. Evidence for a food additive as cause of ketosis-prone diabetes. Lancet 1981; ii: 716–720
   Google Scholar
• Genetics and Environmental Risk Factors for Type 1 Diabetes (IDDM), R. B. Elliott, N. J. Bibby, S. Reddy, Z. Laron, M. Karp. Karger, Freund Publishing House, Basel 1992; 57–62
   Google Scholar
• Karjalainen J., Martin J. M., Knip M., Ilonen J., Robinson B. H., Savilahti E., Akerblom H. K., Dosch H. M. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. New Eng J Med 1992; 327: 302–307
   PubMed Web of Science ®Google Scholar
• Virtanen S. M., Saukkonen T., Savilahti E., Ylonen K., Rasanen L., Aro A., Knip M., Tuomilehto J., Akerblom H. K. and the Childhood Diabetes in Finland Study Group. Diet, cow's milk protein antibodies and the risk of IDDM in Finnish children. Diabetologia 1994; 37: 381–387
   PubMedGoogle Scholar
• Tochino Y. The NOD mouse as a model of type 1 diabetes. CRC Critical Reviews In Immunology 1987; 8: 49–81
   Google Scholar
• Lampeter E. F., Signore A., Gale E. A.M., Pozzilli P. Lessons from the NOD mouse for the pathogenesis and immunotherapy of human Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1989; 32: 703–708
   PubMed Web of Science ®Google Scholar
• Wilson G. L., Leiter E. H. Streptozotocin interactions with pancreatic β cells and the induction of insulin-dependent diabetes. Current Topics Microbiol Immunol 1990; 156: 27–54
   PubMed Web of Science ®Google Scholar
• Like A. A., Rossini A. A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976; 193: 415–417
   PubMed Web of Science ®Google Scholar
• Rossini A. A., Appel M. C., Williams R. M., Like A. A. Genetic influence of the streptozotocin-induced insulitis and hyperglycemia. Diabetes 1977; 26: 916–920
   PubMed Web of Science ®Google Scholar
• Strandell E., Eizirik D. L., Korsgren O., Sandler S. Functional characteristics of cultured mouse pancreatic islets following exposure to different streptozotocin concentrations. Molec Cellular Endocrinol 1988; 59: 83–91
   PubMed Web of Science ®Google Scholar
• Sandler S., Andersson A., Hellerstrom C. Inhibitory effects of interleukin 1 on insulin secrection, insulin biosynthesis and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 1987; 121: 1424–1431
   PubMed Web of Science ®Google Scholar
• Strandell E., Eizirik D. L., Sandler S. Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese-diabetic mice during the phase preceding insulindependent diabetes mellitus. J. Clin Invest 1990; 85: 1944–1950
   PubMed Web of Science ®Google Scholar
• Krebs H. A., Henseleit K. Unterschunggen uber die Harnstoffbildung im Tierkorper, Hoppe-Seylers. Z Physiolo Chem 1932; 210: 33–66
   Google Scholar
• Heding L. G. Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 1972; 8: 260–266
   PubMed Web of Science ®Google Scholar
• Kissane J. M., Robins E. The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. J Biol Chem 1958; 233: 184–188
   PubMed Web of Science ®Google Scholar
• Hinegardner An R. T. improved fluorometric assay for DNA. Analytical Biochem 1971; 39: 197–201
   PubMedGoogle Scholar
• Eisenbarth G. S. Type 1 diabetes mellitus. A chronic autoimmune disease. New Engl J Med 1986; 314: 1360–1368
   PubMed Web of Science ®Google Scholar
• Eizirik D. L., Sandler S., Palmer J. P. pancreatic beta-cells. A relevant phenomenon in early IDDM?. Diabetes 1993; 42: 1383–1391
   PubMed Web of Science ®Google Scholar
• Gerling I. C., Friedman H., Greiner D. L., Shultz L. D., Leiter E. H. Multiple low-dose streptozotoein induced diabetes in NOD scid/scid mice in the absence of functional lymphocytes. Diabetes 1994; 43: 433–440
   PubMed Web of Science ®Google Scholar
• Baxter A. G., Mandel T. E. Accelerated diabetes in non-obese diabetic (NOD) mice differing in incidence of spontaneous disease. Clin and Exp Immunol 1991; 85: 464–468
   PubMedGoogle Scholar
• Reddy S., Frearson N., Liu W., Elliott R. B. Differential sensitivity of NOD mice to diabetes on a protracted low-dose streptozotocin regime. Autoimmunity 1993; 15: 87, Suppl: Abstract
   Google Scholar
• Bonnevie-Nielsen V., Steffes M. W., Lernmark Å. A major loss in islet mass and β-cell function precedes hyperglycemia in mice given multiple low doses of streptozotocin. Diabetes 1981; 30: 424–429
   PubMed Web of Science ®Google Scholar
• Sandler S. Protection by dimethyl urea against hyperglycemia, but not insulitis, in low-dose streptozotocin-induced diabetes in the mouse. Diabetologia 1984; 26: 386–388
   PubMedGoogle Scholar
• Reddy S., Wu D., Elliott R. B. Low dose strepozotocin causes diabetes in severe combined immunodeficient (Scid) mice without immune cell infiltration of the pancreatic islets. Autoimmunity 1995; 20: 83–92
   PubMed Web of Science ®Google Scholar
• Okamoto H. Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin-dependent diabetes. Molec Cellular Biochem. 1981; 37: 43–61
   PubMedGoogle Scholar
• Sandler S., Swenne I. Streptozotocin, but not alloxan, induces DNA repair synthesis in the mouse pancreatic islets in vitro. Diabetologia 1983; 25: 444–447
   PubMedGoogle Scholar
• Turk J., Corbett J. A., Ramanadhan S., Bohrer A., McDaniel M. L. Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem Biophys Res Commun. 1993; 197: 1458–1464
   PubMed Web of Science ®Google Scholar
• Kwon N. S., Lee S. H., Choi C. S., Kho T., Lee H. S. Nitric oxide generation from streptozotocin. FASEB J 1994; 8: 529–533
   PubMedGoogle Scholar
• Eizirik D. L., Pipeleers D. G., Ling Z., Welsh N., Hellerstrom C., Andersson A. Major species differences between humans and rodents in the susceptibility to pancreatic β-cell injury. Proc Natl Acad Sci USA. 1994; 91: 9253–9256
   PubMed Web of Science ®Google Scholar
• Eizirik D. L., Sandler S., Welsh N., Cetkovic-Cvrlje M., Nieman A., Geller D. A., Pipeleers D. G., Bendtzten K., Hellerstrom C. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 1994; 93: 1968–1974
   PubMed Web of Science ®Google Scholar